VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants

VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants

Virus-like particles (VLPs) are a versatile, safe, and highly immunogenic vaccine platform. Recently, there are developmental vaccines targeting SARS-CoV-2, the causative agent of COVID-19. The COVID-19 pandemic affected humanity worldwide, bringing out incomputable human and financial losses. The r...

Full description

Bibliographic Details
Main Authors: Wasim A. Prates-Syed, Lorena C. S. Chaves, Karin P. Crema, Larissa Vuitika, Aline Lira, Nelson Côrtes, Victor Kersten, Francisco E. G. Guimarães, Mohammad Sadraeian, Fernando L. Barroso da Silva, Otávio Cabral-Marques, José A. M. Barbuto, Momtchilo Russo, Niels O. S. Câmara, Gustavo Cabral-Miranda
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Vaccines
Subjects:
virus-like particles
vaccines
COVID-19
SARS-CoV-2
Online Access:https://www.mdpi.com/2076-393X/9/12/1409

Similar Items

Similar Items